Page last updated: 2024-08-21

c.i. 42510 and Adenocarcinoma, Papillary

c.i. 42510 has been researched along with Adenocarcinoma, Papillary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Delotte, J; Ferron, G; Leguevaque, P; Motton, S; Querleu, D; Rafii, A; Vidal, F	1

Other Studies

1 other study(ies) available for c.i. 42510 and Adenocarcinoma, Papillary

Article	Year
Evaluation of the sentinel lymph node algorithm with blue dye labeling for early-stage endometrial cancer in a multicentric setting. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2013, Volume: 23, Issue:7 Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Papillary; Algorithms; Coloring Agents; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Neoplasm Staging; Prognosis; Prospective Studies; Retrospective Studies; Rosaniline Dyes; Sentinel Lymph Node Biopsy	2013

Article

Year

Evaluation of the sentinel lymph node algorithm with blue dye labeling for early-stage endometrial cancer in a multicentric setting.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2013, Volume: 23, Issue:7

Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Papillary; Algorithms; Coloring Agents; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Neoplasm Staging; Prognosis; Prospective Studies; Retrospective Studies; Rosaniline Dyes; Sentinel Lymph Node Biopsy

2013